Blood Res.  2020 Jul;55(S1):S63-S71. 10.5045/br.2020.S011.

Extranodal NK/T cell lymphoma

Affiliations
  • 1Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea

Abstract

Extranodal natural killer (NK)/T cell lymphoma (ENKTL) is a distinct subtype of Non-Hodgkin’s lymphoma mainly involving the nasal area. Since the entity was first recognized, treatment strategies have been evolving from anthracycline-based chemotherapy and radiotherapy to L-asparaginase containing regimens and recently immune checkpoint inhibitors. With the currently used combined chemotherapy and radiotherapy, more than 70% of patients with localized disease can be cured. L-asparaginase containing regimens have significantly improved treatment outcomes among patients with advanced disease. However, the treatment outcomes of patients with disease refractory to L-asparaginase containing regimens or who experience recurrence remain poor. In this article, we cover the current treatments for ENKTL and emerging treatment approaches.

Keyword

Extranodal natural killer/T cell lymphoma; ENKTL; Non-Hodgkin’s lymphoma; Immunotherapy
Full Text Links
  • BR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error